TRAF3IP2 Polyclonal Antibody

TRAF3IP2 Polyclonal Antibody

The TRAF3IP2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of TRAF3IP2 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques and exhibits exceptional sensitivity and specificity.

TRAF3IP2, also known as Act1, is a crucial adaptor protein involved in the regulation of various signaling pathways, including those mediated by Toll-like receptors (TLRs) and Interleukin-17 (IL-17) family cytokines. It plays a pivotal role in the activation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling cascades, thereby influencing immune responses and inflammatory processes.

The TRAF3IP2 Polyclonal Antibody has been extensively validated for its performance in Western blotting, immunohistochemistry, and immunofluorescence applications. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. With its high affinity and specificity, this antibody enables precise detection and quantification of TRAF3IP2 protein expression in a wide range of experimental settings.

This antibody is supplied as a liquid formulation in a convenient size of 100 μg, ensuring ample quantity for multiple experiments. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps. The TRAF3IP2 Polyclonal Antibody is compatible with various detection systems and can be used in both research and clinical settings.

In summary, the TRAF3IP2 Polyclonal Antibody is a valuable tool for researchers and clinicians studying the role of TRAF3IP2 in immune responses and inflammatory processes. Its exceptional sensitivity, specificity, and ease of use make it an indispensable asset for a wide range of applications, facilitating accurate and reliable analysis of TRAF3IP2 protein expression.